Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9934321 | 0.82 | HDAC8 (0.34) | HTTHDAC8 | |
| SCHEMBL9934923 | 0.81 | HDAC8 (0.33) | HTTHDAC8 | |
| SCHEMBL9934925 | 0.81 | HDAC8 (0.33) | HTTHDAC8 | |
| Sulfuric Acid SCHEMBL2866335 | 0.80 | HDAC8 (0.42) | HTTHDAC8KDM4EAPOBEC3ASMN1; SMN2 | |
| Sulfuric Acid SCHEMBL2866328 | 0.79 | HDAC8 (0.45) | HTTHDAC8KDM4EAPOBEC3ASMN1; SMN2 | |
| SCHEMBL9935127 | 0.78 | HTT (0.35) | HTTHDAC8KDM4EAPOBEC3ASMN1; SMN2 | |
| SCHEMBL1293196 | 0.78 | HDAC8 (0.43) | HTTHDAC8KDM4EAPOBEC3ASMN1; SMN2 | |
| Acetic Acid SCHEMBL17238894 | 0.74 | HDAC8 (0.43) | HTTHDAC8KDM4EAPOBEC3ASMN1; SMN2 | |
| SCHEMBL9935224 | 0.74 | HDAC8 (0.33) | HTTHDAC8 | |
| SCHEMBL9936187 | 0.74 | FDPS (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8546609-B2 | Ionic liquid containing allylsulfonate anion | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2013-10-01 | — | — | US | disclosed |
| EP-2474527-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | Wako Pure Chemical Industries, Ltd. (JP) | 2012-07-11 | — | — | EP | disclosed |
| US-20120157680-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2012-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120157680-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | ATXN2L, ARL1, INPPL1 | HTT 3354/4885HDAC8 4800/4885KDM4E 4681/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.